Regulation of RNA Polymerase II Activity and Gene Expression By RPS7P3

Target Name: RPS7P3

NCBI ID: G440732

RPS7P3

Other Name(s): RPS7_2_175 | ribosomal protein S7 pseudogene 3 | Ribosomal protein S7 pseudogene 3

Regulation of RNA Polymerase II Activity and Gene Expression By RPS7P3

RPS7P3 (RPS7P3_2_175) is a protein that is expressed in various tissues and cell types in the human body. It is a key regulator of the Replicative Polynucleotide System (RPS), which is a complex of RNA polymerase II and other proteins that are involved in the production of DNA in the cell. Mutations in the RPS7P3 gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, RPS7P3 has become a focus of interest in the search for new drug targets and biomarkers.

The RPS is a highly conserved complex that is involved in the production of DNA from RNA in the cytoplasm of the cell. The RPS consists of several proteins, including RNA polymerase II, which is the primary enzyme responsible for this process. Other proteins in the RPS include key components of the complex, such as the protein encoded by the RPS7P3 gene.

The RPS7P3 gene is located on chromosome 16 and encodes a protein with 215 amino acid residues. The protein has several important functions in the RPS, including the regulation of RNA polymerase II activity and the structure of the replicative complex. In addition, the RPS7P3 protein has been shown to play a role in the regulation of gene expression and in the development of various diseases.

One of the most significant functions of the RPS7P3 protein is its role in the regulation of RNA polymerase II activity. RNA polymerase II is a key enzyme in the production of DNA from RNA, and it is dependent on the RPS for its function. The RPS7P3 protein is shown to play a critical role in the regulation of RNA polymerase II activity by interacting with the enzyme's active site. This interaction allows the RPS7P3 protein to regulate the speed at which RNA polymerase II begins to synthesize DNA.

In addition to its role in regulating RNA polymerase II activity, the RPS7P3 protein has also been shown to play a role in the regulation of gene expression. The RPS7P3 gene has been shown to be involved in the regulation of gene expression by the RNA polymerase II complex. This is based on the fact that the RPS7P3 protein has been shown to interact with the RNA polymerase II complex, and this interaction is thought to play a role in the regulation of gene expression.

The RPS7P3 protein has also been linked to a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that mutations in the RPS7P3 gene are associated with an increased risk of cancer, including breast cancer. In addition, the RPS7P3 protein has also been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Despite the potential importance of the RPS7P3 protein in the regulation of various diseases, the function of this protein is not yet fully understood. As a result, the search for new drug targets and biomarkers associated with the RPS7P3 protein is an active area of research.

In conclusion, RPS7P3 (RPS7P3_2_175) is a protein that is expressed in various tissues and cell types in the human body and plays a critical role in the production of DNA from RNA in the cytoplasm of the cell. The RPS is a highly conserved complex that is involved in the regulation of various cellular processes, including the production of DNA. The RPS7P3 protein has been shown to play a

Protein Name: Ribosomal Protein S7 Pseudogene 3

The "RPS7P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS7P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets